Orthostatic hypotension is associated with incident chronic kidney disease: The Atherosclerosis Risk In Communities Study

Background— Orthostatic hypotension (OH) is associated with increased rates of cardiovascular disease and mortality, particularly among middle-aged persons. However, little is known about the association of OH with chronic kidney disease (CKD). Methods and Results— Postural changes in blood pressure (BP) were estimated using the difference between the average of multiple supine and standing BP measurements. OH was defined as a decrease in systolic BP ≥ 20 mm Hg, or a decrease in diastolic BP ≥ 10 mm Hg upon standing. Incident CKD was defined as an increase in serum creatinine ≥ 0.4 mg/dL at the 3- or 9-year follow-up visits, or a hospitalization (discharge) or death due to CKD. Urinary albumin-to-creatinine ratio (ACR, mg/g) was obtained at visit 4 and used to define albuminuria (ACR ≥ 30 mg/g). The association between OH and incident CKD and between OH and categories of albuminuria were modeled using adjusted Cox proportional hazard models and logistic regression, respectively. Among 12,593 individuals, 1,019 developed CKD (3.9 cases/1,000 person-years) over a mean of 16 years. A significantly increased risk of CKD was observed among individuals with OH compared to those without OH after adjustment (hazard ratio 1.67, 95% confidence interval, 1.36, 2.06). OH was associated with increased risk of albuminuria (OR 1.66, 95% CI 1.21, 2.29). Conclusions— These findings suggest that OH increases the risk of CKD in middle-aged persons. Multiple physiologic mechanisms are activated in response to gravitational pooling of blood, reduced venous return and reduced cardiac output. The autonomic nervous system, particularly the sympathetic nervous system, has an important role in the short-term regulation of blood pressure (BP). 1 Individuals with autonomic dysfunction are unable to regulate BP in response to postural changes. Orthostatic hypotension (OH), a manifestation of autonomic dysfunction, is associated with incident hypertension 2 , coronary heart disease 3 , stroke 4 and all-cause mortality 5 in middle-aged persons.

[1]  O. Melander,et al.  Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (The Malmö Preventive Project) , 2009, European heart journal.

[2]  Karin Kraft,et al.  [Type-2 diabetes]. , 2010, MMW Fortschritte der Medizin.

[3]  A. Köttgen,et al.  Defining incident chronic kidney disease in the research setting: The ARIC Study. , 2009, American journal of epidemiology.

[4]  M. Esler,et al.  Sympathetic activation in chronic renal failure. , 2009, Journal of the American Society of Nephrology : JASN.

[5]  D. Goldstein,et al.  Neurogenic Orthostatic Hypotension: A Pathophysiological Approach , 2009, Circulation.

[6]  B. Wallin,et al.  A sympathetic view of the sympathetic nervous system and human blood pressure regulation , 2008, Experimental physiology.

[7]  R. Freeman,et al.  Clinical practice. Neurogenic orthostatic hypotension. , 2008, The New England journal of medicine.

[8]  C. Tseng,et al.  Prevalence and severity of renal disease in familial dysautonomia. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  A. Sharrett,et al.  Orthostatic Hypotension Predicts Mortality in Middle-Aged Adults: The Atherosclerosis Risk in Communities (ARIC) Study , 2006, Circulation.

[10]  Y. Kida Apolipoprotein E and progression of chronic kidney disease. , 2006, JAMA.

[11]  P. Whelton,et al.  Effect of Blood Pressure on Early Decline in Kidney Function Among Hypertensive Men , 2003, Hypertension.

[12]  A. Sharrett,et al.  Association between the blood pressure response to a change in posture and the 6-year incidence of hypertension: prospective findings from the ARIC study , 2002, Journal of Human Hypertension.

[13]  C. Lang,et al.  Increased Vascular Adrenergic Vasoconstriction and Decreased Vasodilation in Blacks: Additive Mechanisms Leading to Enhanced Vascular Reactivity , 2000, Hypertension.

[14]  Daniel W. Jones,et al.  Orthostatic Hypotension as a Risk Factor for Stroke: The Atherosclerosis Risk in Communities (ARIC) Study, 1987–1996 , 2000, Stroke.

[15]  J. Coresh,et al.  Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. , 2000, Kidney international.

[16]  A. Sharrett,et al.  Orthostatic hypotension and the incidence of coronary heart disease: the Atherosclerosis Risk in Communities study. , 2000, American journal of hypertension.

[17]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[18]  M. Cirillo,et al.  Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: The Gubbio Population Study. , 1998, Archives of internal medicine.

[19]  A. Folsom,et al.  Body weight change and carotid artery wall thickness. The Atherosclerosis Risk in Communities (ARIC) Study. , 1998, American journal of epidemiology.

[20]  P. Whelton,et al.  End-stage renal disease in African-American and white men. 16-year MRFIT findings. , 1997, JAMA.

[21]  K. Iseki,et al.  Blood pressure and risk of end-stage renal disease in a screened cohort. , 1996, Kidney international. Supplement.

[22]  J. Jankovic,et al.  Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy , 2005, Clinical Autonomic Research.

[23]  P. Whelton,et al.  Blood pressure and end-stage renal disease in men. , 1996, The New England journal of medicine.

[24]  A. Folsom,et al.  Variability in B-mode ultrasound measurements in the atherosclerosis risk in communities (ARIC) study. , 1996, Ultrasound in medicine & biology.

[25]  J. Miller,et al.  Early predictors of 15-year end-stage renal disease in hypertensive patients. , 1995, Hypertension.

[26]  J J Smith,et al.  Hemodynamic Response to the Upright Posture , 1994, Journal of clinical pharmacology.

[27]  L. Chambless,et al.  Short-term, within-person variability in clinical chemistry test results. Experience from the Atherosclerosis Risk in Communities Study. , 1994, Archives of pathology & laboratory medicine.

[28]  P. Whelton,et al.  A Prospective Study of Blood Pressure and Serum Creatinine: Results From the 'Clue' Study and the ARIC Study , 1993 .

[29]  R. Neuwirth,et al.  Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group. , 1992, JAMA.

[30]  L. Chambless,et al.  Measuring Ankle Systolic Blood Pressure: Validation of the Dinamap 1846 SX , 1992, Angiology.

[31]  L. Chambless,et al.  High‐Resolution B‐Mode Ultrasound Reading Methods in the Atherosclerosis Risk in Communities (ARIC) Cohort , 1991, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[32]  H. Dustan,et al.  Renal insufficiency in treated essential hypertension. , 1989, The New England journal of medicine.